For instance, in HNSCC, PD-L1 is predominantly expressed in antigen-presenting cells (APCs) and tumour cells, whereas PD-L2 is predominantly present in a broad range of immune cells, including macrophages and myeloid-derived mast cells. Here, PDCD1LG2 is linked to neoplasm.